secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2026-08-06T20:09:56+00:00
Accession:  0001437402-26-000043
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx Q2 revenue up 31% to $118.1M; cuts FY2026 IBSRELA guidance to $350-370M
-------------------------------------------------------------------------------

- Q2 total product revenue $118.1M (+31% YoY); IBSRELA $86.2M (+33%), XPHOZAH $31.9M (+27%).
- Net loss $16.7M ($0.07/sh) vs $19.1M ($0.08) prior year; cash $281.8M.
- FY2026 IBSRELA guidance revised to $350-370M; XPHOZAH reiterated $110-120M; OPEX below $500M.
- Long-term IBSRELA $1B target remains but timing uncertain; XPHOZAH long-term guidance pulled.
- Drew $50M from SLR facility; CMS lawsuit dismissed, not appealing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000143740226000043/0001437402-26-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000143740226000043/ardx-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001437402-26-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer